• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

August 26, 2022

Chronic Health Conditions, Smoking Contribute to Worse Health-Related Quality of Life Among Adult Survivors of Childhood Cancer

Author(s):

Lindsey Mulrooney

Risk factors associated with declining health-related quality of life for adult survivors of childhood cancer, such as physical inactivity and chronic health conditions, should be targets of surveillance and intervention.

For adult survivors of childhood cancer experiencing declining health-related quality of life (HRQOL), chronic health conditions are associated with a decline in physical HRQOL, and current smoking and emotional and neurocognitive impairment were associated with a decline in mental HRQOL, according to a study published in JAMA Network Open. Interventions targeting modifiable risk factors may be needed to prevent poor HRQOL in this population.

Though the 5-year survival rate for childhood cancer has increased to more than 85%, this progress is tempered by adverse consequences of treatment and premature mortality. By 50 years of age, nearly 100% of survivors develop chronic health conditions, impacting HRQOL.

Researchers sought to identify risk factors for suboptimal and declining HRQOL that could be targeted in future interventions during follow-up care appointments.

They conducted a prognostic study to describe the prevalence of future suboptimal and declining HRQOL over time and to examine the performance of models developed to predict suboptimal and declining HRQOL. They also aimed to identify sociodemographic, lifestyle, and health state factors associated with future suboptimal and declining HRQOL.

The study included 4755 adults from the Childhood Cancer Survivor Study diagnosed between January 5, 1970, and December 31, 1986, who completed baseline and 2 follow-up and time 2 surveys. Participants included patients who had been diagnosed and treated for childhood cancer at younger than 21 years of age at institutions in the United States and Canada. HRQOL was operationalized using the Medical Outcomes Study 36-item Short Form Health Survey Physical and Mental Component Summary and classified by optimal or suboptimal at each point.

The analysis included 4755 adults (mean [SD] age at time 0, 24.3 [7.6] years; 2623 [55.2%] women). Between time 1 and time 2, 285 of 3294 survivors (8.7%) were found to have declining PCS and 278 of 3294 (8.4%) were found to have declining MCS.

Additionally, 5.3% to 6.3% of survivors reported persistently suboptimal HRQOL. The researchers identified risk factors associated with PCS decline, including female sex, family income less than $20,000 compared with $80,000 or more, presence of chronic health conditions, and depression.

Risk factors associated with MCS decline included physical inactivity, unemployment compared with full-time employment, current compared with never smoking cigarettes, depression, somatization, impaired task efficiency, and impaired organization. The authors of the study hope these findings can help guide the design of future interventions to prevent HRQOL decline.

“The implications of this work allow clinicians to speak to cancer survivors about the likelihood of maintaining poor or worsening HRQOL in the presence of specific risk factors or, more importantly, how alterations or elimination of risk factors might help improve HRQOL over time,” the authors wrote.

They encourage surveillance of these risk factors within the context of follow-up care appointments. When the presence of these factors is identified, they note that recommendations for referral to appropriate interventions are warranted.

“Given the growing number of cancer survivors, there continues to be an urgent need to identify those survivors who are at greatest risk and implement novel research toward improving their HRQOL,” the authors concluded.

The study has some limitations. The risk prediction model for HRQOL developed and validated in this study was based on the CCSS cohort alone. Validation by an external cohort was not possible as a comparable cohort was not available at the time of the study.

Additionally, researchers found that participants who completed both the time 1 and time 2 questionnaires were more likely to be women and non-Hispanic White, have a college graduate or post-graduate educational level, and to have higher annual household income. Therefore, the findings may not be generalizable to a larger, more diverse population. They encourage additional research with a more diverse sample of survivors.

Reference

Schulte F, Chen Y, Yasui Y, et al. Development and validation of models to predict poor health-related quality of life among adult survivors of childhood cancer. JAMA Netw Open. 2022;5(8):e2227225. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2795248. Published August 17, 2022. Accessed August 18, 2022.

Related Videos
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP
May 13th 2025

Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP

Juliana Chan, PharmD, FCCP, BCACP PT Staff
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Ozempic, Mounjaro and Wegovy injectable pens on white background - Image credit: K KStock | stock.adobe.com
May 12th 2025

Expert Q&A: Expanding the Pharmacist's Role in Community-Based Weight Management

Emilie Collongette, PharmD, CPh, BCMTMS Kennedy Ferruggia, Assistant Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Pharmacist Champion Role Improves Access to Resmetirom for MASH
May 12th 2025

Pharmacist Champion Role Improves Access to Resmetirom for MASH

Brian Gaul, PharmD
Can Low-Dose Naltrexone Fill the Gaps in Palliative Pain Management?
May 12th 2025

Can Low-Dose Naltrexone Fill the Gaps in Palliative Pain Management?

Emma Murter, PharmD, MPH Madison N. Irwin, PharmD, BCPS Alana Hippensteele, Lead Editor
Related Content
Advertisement
Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP
May 13th 2025

Pharmacist Spotlight: Juliana Chan, PharmD, FCCP, BCACP

Juliana Chan, PharmD, FCCP, BCACP PT Staff
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Ozempic, Mounjaro and Wegovy injectable pens on white background - Image credit: K KStock | stock.adobe.com
May 12th 2025

Expert Q&A: Expanding the Pharmacist's Role in Community-Based Weight Management

Emilie Collongette, PharmD, CPh, BCMTMS Kennedy Ferruggia, Assistant Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Pharmacist Champion Role Improves Access to Resmetirom for MASH
May 12th 2025

Pharmacist Champion Role Improves Access to Resmetirom for MASH

Brian Gaul, PharmD
Can Low-Dose Naltrexone Fill the Gaps in Palliative Pain Management?
May 12th 2025

Can Low-Dose Naltrexone Fill the Gaps in Palliative Pain Management?

Emma Murter, PharmD, MPH Madison N. Irwin, PharmD, BCPS Alana Hippensteele, Lead Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.